FOXO4-DRI 10mg

FOXO4-DRI is an advanced synthetic senolytic peptide engineered to selectively target senescent cells — often referred to in research literature as “zombie cells.” These dysfunctional cells accumulate over time and are heavily studied for their association with aging, inflammation, and tissue degeneration pathways. Research surrounding FOXO4-DRI has expanded rapidly due to its unique mechanism involving disruption of the FOXO4-p53 interaction.

This peptide utilizes D-retro-inverso (DRI) technology, a structural modification designed to improve peptide stability and resistance to enzymatic degradation while maintaining biological targeting capability. In laboratory models, FOXO4-DRI has demonstrated selective senolytic activity by inducing apoptosis in senescent cells while sparing healthy cells under studied conditions.

FOXO4-DRI has become a major focus in longevity, regenerative medicine, and cellular aging research because of its highly targeted pathway approach compared with broader senolytic compounds.

Key Research Areas

• Cellular senescence research
• Longevity and healthy aging studies
• FOXO4-p53 pathway interaction
• Senolytic peptide mechanisms
• Inflammaging and SASP-related research
• Tissue regeneration and recovery models
• Advanced peptide stability studies

Product Specifications

• Peptide: FOXO4-DRI
• Quantity: 10mg
• Format: Lyophilized powder
• Grade: Research-use peptide
• Purity: High-purity laboratory standard
• Storage: Store refrigerated or frozen in a dry environment
• Intended Use: Scientific and laboratory research only

Why Researchers Study FOXO4-DRI

FOXO4-DRI stands apart from traditional peptides because it is specifically engineered for senolytic research applications rather than hormone modulation or performance pathways. Preclinical research has explored its potential role in selective senescent cell clearance and restoration of tissue function in aging models.

Its D-retro-inverso structure also makes it particularly interesting in peptide engineering research due to enhanced molecular stability and resistance to proteolytic breakdown.

Important Notice

This product is intended strictly for laboratory and scientific research purposes only. Not for human consumption, medical use, or diagnostic applications. This compound is not approved for therapeutic or pharmaceutical use. Keep out of reach of children.